1. Home
  2. MMED

as of 07-20-2026 12:15pm EST

$17.12
+$0.30
+1.80%
Stocks Health Care Medical/Dental Instruments Nasdaq

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

Founded: 1983 Country:
United States
United States
Employees: 2800 City: NORTHRIDGE
Market Cap: 4.3B IPO Year: 2026
Target Price: $22.56 AVG Volume (30 days): 1.1M
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $10.65 - $17.86 Next Earning Date: 06-03-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 15.99% Revenue Growth (next year): 10.00%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: